<DOC>
	<DOC>NCT00828464</DOC>
	<brief_summary>The purpose of the study is to assess the safety, efficacy and tolerability of Clobetasol propionate foam in subjects with chronic dermatitis.</brief_summary>
	<brief_title>Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand Dermatitis</brief_title>
	<detailed_description>The study is being conducted in order to obtain safety, efficacy and tolerability data for Clobetasol propionate foam in the treatment of chronic dermatitis. The subjects must have mild to moderate disease based on the Investigator's assessment at baseline.</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Hand Dermatoses</mesh_term>
	<mesh_term>Clobetasol</mesh_term>
	<criteria>Subjects 18 years of age or older, with diagnosis of chronic dermatitis, able to complete the study and comply with study instructions. Female subjects of childbearing potential must have a negative pregnancy test. Sexually active women of childbearing potential participating in the study must have been using a medically acceptable form of contraception Use of systemic corticosteroid and/or other prohibited medications within 4 weeks of the baseline visit. Use of topical corticosteroid therapy and/or other prohibited topical medications within 2 weeks prior to the baseline visit</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Dermatosis, Dermatitis, Dry skin, Irritated skin</keyword>
</DOC>